FDA Grants Accelerated Approval to Atrasentan for IgA Nephropathy Dr. Kamal Kant Kohli5 April 2025 9:30 AM ISTThe US FDA has granted accelerated approval to atrasentan (Vanrafia) for reducing proteinuria in adults with primary immunoglobulin A (IgA)...
How novel antibody felzartamab impacts IgA nephropathy? Dr. Kamal Kant Kohli3 Feb 2025 8:30 PM ISTIgA nephropathy (IgAN) is an autoimmune kidney disease driven by immune cells that express a protein called CD38 on their surface. A recent Phase 2...
Metabolic Syndrome components significantly associated with prognosis of IgA nephropathy, finds study Dr Kartikeya Kohli22 Jan 2025 8:15 PM ISTMetabolic Syndrome components significantly associated with prognosis of IgA nephropathy, finds study published in the Scientific Reports.Metabolic...
Study reveals Pathogenic role of dental caries-causing bacteria in IgA nephropathy Dr. Kamal Kant Kohli3 Dec 2024 9:00 PM ISTThe kidneys act as a filtering system in the human body that help in the removal of excess fluids and unwanted wastes from the bloodstream....
Sibeprenlimab Reduces Protein Levels in Adults with IgA Nephropathy shows Phase 3 VISIONARY study Medha Baranwal8 Nov 2024 8:15 PM ISTUSA: An interim analysis of the Phase 3 VISIONARY study revealed that sibeprenlimab achieved a significant and clinically meaningful reduction in the...
C4d Identified as Independent Predictor of Disease Progression in IgA Nephropathy in new research Dr Kartikeya Kohli22 Sept 2024 10:00 PM ISTResearchers have demonstrated that primary IgA nephropathy (IgAN) may potentially be linked with an independent predictor of disease progression in...
Reduced-Dose Methylprednisolone Boosts Kidney Health in High-Risk IgAN but Increases SAEs: TESTING analysis Dr Kartikeya Kohli19 Sept 2024 5:00 AM ISTAustralia: A tapered regimen of reduced-dose oral methylprednisolone administered over 6 to 9 months significantly enhances kidney outcomes in...
Study Shows Variable Response to Spironolactone in IgA Nephropathy; Safety Confirmed in Higher eGFR Patients Medha Baranwal16 Sept 2024 4:30 AM ISTChina: A recent study published in Kidney and Blood Pressure Research has validated that spironolactone effectively reduces urine protein excretion in...
FDA approves Sparsentan for proteinuria reduction in IgAN Dr. Kamal Kant Kohli7 Sept 2024 5:00 AM ISTThe US Food and Drug Administration has granted full approval to sparsentan (Filspari) for reduction of proteinuria in adults with IgAN at risk of...
Elevated cathepsin S levels linked to increased IgAN risk, reveals research Medha Baranwal28 July 2024 8:45 PM ISTChina: Higher levels of cathepsin S (CTSS) may be linked to an increased risk of IgA nephropathy (IgAN), a recent study has found.The findings,...
Chronic Tonsillitis Linked to Increased Risk of IgA Nephropathy, Study Finds Dr Riya Dave8 July 2024 5:45 AM ISTResearchers have identified a significant association between chronic tonsillitis and the risk of developing IgA nephropathy (IgAN), a kidney...
Metabolic Syndrome Increases CV and Renal Risks in IgA Nephropathy Patients, suggests study Jacinthlyn Sylvia4 July 2024 8:15 AM ISTA recent study published in Biosciences Journal found that individuals with IgA nephropathy (IgAN) are at higher risk of cardiovascular (CV) mortality...
